Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Beyfortus
Pharma
FDA signs off on Enflonsia, Merck's RSV shot for infants
The FDA has blessed Merck’s clesrovimab to protect against lower respiratory tract disease related to RSV in newborns and infants.
Kevin Dunleavy
Jun 9, 2025 4:33pm
Sanofi has already produced as much Beyfortus as it sold in 2024
Jun 9, 2025 11:14am
Sanofi aims to grow Beyfortus after blockbuster sales year
Jan 30, 2025 11:45am
JPM25: CEOs encourage 'transparency' amid US anti-vaccine push
Jan 14, 2025 4:01pm
Sanofi isn't sweating a potential RSV showdown with Merck
Oct 25, 2024 11:12am
Sanofi, AZ look to avoid Beyfortus shortfalls this year
Sep 17, 2024 11:33am
